RADIOIMMUNOASSAY OF MAMMALIAN TYPE C VIRAL PROTEINS : III. DETECTION OF VIRAL ANTIGEN IN NORMAL MURINE CELLS AND TISSUES by Parks, Wade P. et al.
RADIOIMMUNOASSAY OF  MAMMALIAN TYPE  C  VIRAL 
PROTEINS 
III. DETECTION OF VIRAL ANTIGEN IN NORMAL MURINE  CELLS AND TISSUES 
BY  WADE  P.  PARKS,  DAVID  M. LIVINGSTON,  GEORGE  J.  TODARO, 
RAOUL E.  BENVENISTE, AND EDWARD  M.  SCOLNICK 
(From the Viral Carcinogenesis  Branch and the Viral Leukemia and Lymphoma Branch, 
National Cancer Institute, National Institutes of Health, Bethesda,  Maryland 20014) 
(Received for publication 26 October 1972) 
Induction of infectious type C viruses by physical and chemical means from avian 
and routine cells  (1-4)  strongly supports the view that most, if not all, mouse and 
chicken cells contain at least one normally repressed copy of a complete type C viral 
genome (5). The state of this endogenous viral information is presently unclear. The 
recent development of a radioimmunoassay for the major internal viral protein (6-8), 
the group-specific  (gs) ~  antigen of murine type C viruses (9-] 2), provides a method for 
the detection of small quantities of this protein in routine cells below the level of sensi- 
tivity of complement  fixation or gel diffusion assays (9, ] 1, 13). 
Using this technique, we have been able to measure an immunological reac- 
tivity that is similar to the virion gs protein in both virus-producing and virus- 
free mouse cell lines and also in natural nontumored murine tissues. The find- 
ings reported here provide additional evidence for  the widespread prevalence 
of type C viral genes in a variety of mouse cells and strongly suggest a low level 
of  synthesis of  at  least  one virion protein both  in apparently virus-negative 
tissues in the animal and in virus-free cultured cells. 
Materials and Methods 
Cdls.--The cell lines and strains listed in Table I were employed for the present studies. 
Cells were grown and maintained with Dulbecco's modification of Eagle's  medium supple- 
mented with either 10% calf serum or 10% fetal calf serum (Colorado Serum Co., Denver, 
Colo.). 
Virus.--The Rauscher strain of rnuriue leukemia virus  (MuLV) was obtained from Elec- 
tro-Nucleonics, Bethesda,  Md., as twice sucrose density gradient purified material  concen- 
trated 1,000-2,000-fold  relative to the starting material. 
Antigens  and Antisera.--The preparation  of murine  gs  antigen  [MVP3(gs)], the major 
polypeptide (30,000 daltons), from disrupted MuLV by Sephadex G-100 gel chromatography 
and electrophoresis  in ampholytes has been described (5), as has the preparation and specificity 
testing of rabbit anti-MVP3(gs)  (6). Cell extracts were prepared by several methods designed 
to solubilize maximally the gs reactivity. Generally, cell monolayers were washed one to two 
times with phosphate-buffered saline, pH 7.2, and after removal with a rubber policeman, pre- 
1 Abbr~iations  used in  this paper: CF,  complement fixation; gs, group specific; MuLV, 
murine leukemia virus; MVP3(gs), murine group-specific antigen; NRK, normal rat kidney. 
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pared  as 20%  (vol/vol) extracts.  Subsequent  treatments included two cycles of freezing at 
--70°C and rapid thawing, treatment with 1% Triton X-100 and 0.7% deoxycholate in 2 M 
KC1, followed by removal of the Triton with ether and dialysis to remove the salt and deoxy- 
cholate. These procedures improved the yield of murine cellular gs reactivity by 40-60% over 
repeated freeze-thawings comparable to the results previously reported by Fleissner (21) foi 
the extraction of avian gs antigen(s) from hamster cells. 
A~nity Chromatographic Procedures.--The method of preparation and coupling to Sepharose 
of the goat IgG was that described previously for rabbit IgG (22). IgG was coupled to Sepha- 
rose 4B using a ratio of Sepharose to protein of 30/1  (wt/wt) ; cell extracts were applied to the 
column in 2-3 ml of buffer containing: 0.05 M  Tris-HC1,  pH 7.8; 0.30  M  KC1;  2% Triton 
X-100; and 10 mg/ml of bovine serum albumin (buffer A). After 5-10 rain  to allow for equil- 
ibration, the column was washed with 10 ml of buffer A; followed  by 10 ml of 0.05  M  Tris- 
HC], pH 7.8, and 0.30 M  KC1  (buffer  B); and eluted with 15-20  ml of 1.0 M  NH4OH and 
0.30 M KC1 (solution  C). Fractions of each wash (1.0 ml) were collected and were then dialyzed 
overnight against 0.05 M  Tris-HCl, pH 7.8. Concentration of pooled positive fractions to a 
volume of 0.5-1.0  ml by ultrafiltlation was performed in an Amicon concentration  device 
(Amicon Corp.,  Lexington,  Mass.)  using  a  PM-10  filter. Recovery of antigenic  reactivity 
through these procedures averaged 50% of the reactivity in the starting material in repeated 
experiments. Regenelation of columns was as described (22). 
Assays.--Protein determinations were performed by the Lowry method using bovine serum 
albumin (Pentex Biochemical, Kankakee, I]].) as a standard  (23). The radioimmunoprecipita- 
tion assay for the murine intraspecies group-specific  antigen and the preparation of l~SI-labeled 
MVP3(gs)  were as  described  (6) with the following  minor modifications. All dilutions were 
made in 0.01%  (vol/vol) Triton X-100 with 1% normal rabbit serum (6.8 mg/ml) as carrier 
in 0.01 M potassium phosphate, pH 7.8. This concentration of rabbit serum was determined 
by prior titrations to provide the optimal amount of carrier IgG for maximal precipitation of 
marker [125I]rabbit IgG. 
Data Analysis.--Dose-response curves generated  by radioimmunoprecipitation inhibition 
assays were normalized to 100%  to facilitate interassay comparability and linearized by logit 
transformation  (24).  Regression analysis of linearized dose-response  curves was by the un- 
weighted ]east squares method and subsequent comparison of slopes  and intercepts was done 
using the standard  Student's t test.  Computational analysis and  data plotting were greatly 
facilitated  by  a  Honeywell  1340 computer  programmed  for  radioimmunoassay  by  Steve 
Watson, Meloy Laboratories, Springfield,  Va. 
Nucleic Acid llybridizations.--The procedures employed for the synthesis of [3H]thymidine 
DNA product from KiMuLV(Ki-MSV) virus preparations grown in normal rat kidney (NRK) 
cells (17) and hybridization methods using S-1 nuclease are as described (25, 26). Over 70%  of 
the [3H]thymidine  DNA product hybridized to 70S RNA from purified MuLV virions (26). 
RESULTS 
Measurement  of  Antigen  in  Murine  Tissue  Culture  Cells.--By  using  the 
radioimmunoassay,  uninfected murine tissue culture cells were found to contain 
measurable levels of antigen that cross-reacted with MuLV gs. Estimates of the 
concentrations  noted  in  several  representative  murine,  rat,  and  human  cell 
systems with and without known exogenous virus infections are shown in Fig. 1. 
The  expressed  values  can  be  compared  with  one  another;  however,  absolute 
quantitation  assumes  that  the  antigen  detected  in  cells  is  immunologically 
comparable  to  purified  MVP3(gs)  since  the  antigen  levels are  determined  by 
reference to the  10%  intercept on a  linearized standard  dose-response  curve of 624  DETECTION  OF  VIRAL  ANTIGEN  BY  RADIOIMMUNOASSAY 
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Fig.  1.  Dose-response curve of crude antigen preparations. 20%  (vol/vol) cell extracts of 
NRK  (O .... O)  (21.5  mg/ml),  BALB/c  3T3  clone A31  (V--V)  (6.2  mg/ml),  NIH  3T3 
(e--O)  (9.0 mg/ml), and disrupted R-MuLV (A--A)  (0.00052 mg/ml) were assayed at the 
dilutions indicated using radioimmunoprecipitation inhibition of  [125I]MVP3(gs)  as described 
(6, 7) with rabbit anti-MVP3(gs). Maximum cpm were 8,110 and in the presence of antibody 
without added unlabeled antigen, 2,268. 
purified MVP3(gs)  protein. Two cell  lines producing murine leukemia virus, 
KiMuLV(Ki-MSV)-NRK and HEK-HRV, produce approximately 1,000 times 
more viral antigen per milligram of total cell protein than cultures not releasing 
virus. Since the MuLV measured grows in cells of heterologous species  (rat and 
human), the reaction is virus specific. 
Levels  of  antigen  in  contact-inhibited,  virus-negative  monolayer cultures 
shown in Table  I  ranged from  16  to 36  ng/mg protein.  Levels varied from 
preparation  to  preparation;  however,  repeated  determinations  on  the  same 
preparation did not vary by more than 30 % of the mean. It was of interest that 
several  lines  of  non-producer-transformed  cells  derived  by  four  separate 
methods,  SV40  transformation,  murine  sarcoma  virus  transformation,  X- 
irradiation-induced, or "spontaneous" transformation, had comparable levels 
of antigenic reactivity. This indicated that transformation per se, and particu- 
larly nonproducer  "sarcoma" virus  infection (17),  does not result  in  signifi- 
cantly (< 2-fold) increased levels of gs reactivity compared with untransformed 
cells. 
Attempts  to  recover  infectious virus from the  cell  lines  listed in Table  I 
other than the producer cultures have been negative. Similarly the cells have 
been  regularly  tested  and  found  negative  for  viral  RNA-instructed  DNA 
polymerase and morphological type C particles by electron microscopy. 
Several specificity tests of the radioimmunoassay reaction were performed. 
First,  in the mouse species-specific  (gs-1)  assay, normal rat cells  and human 
fibroblasts were negative, suggesting the reactivity is specific for mouse cells. 
Secondly, mouse cells were negative in species-specific  radioimmunoassays for PARKS, LIVINGSTON~ TODARO, BENVENISTE, SCOLNICK 
TABLE I 
Radioimmunoassay oJ Type C Autigeniv Reactivity in Virus and Cell Extracts 
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Species 
Mouse 
Rat 
Human 
Cell line or strain 
BALB/c 3T3 clone A31 
SVA31 clone 5 
KA31 
R4 
3T12 line 3 
NIH Swiss 3T3 
KNRK 
KiMuLV (MSV)-NRK 
NRK 
HEK-HRV 
Woolly monkey, infected 
M413B 
M413B 
Referenc 
(14) 
(14) 
(14) 
(15) 
(14) 
(16) 
(17) 
(17) 
(18) 
(19) 
(2O) 
(20) 
Phenotype 
Normal 
Transformed 
Transformed 
Transformed 
Transformed 
Normal 
Transformed 
Transformed  (virus 
producing) 
Normal 
Normal  (virus pro- 
ducing) 
Normal 
Normal 
Average 
concentra- 
tion of 
reactivity* 
ng/mg 
19 
29 
16 
22 
36 
26 
<1 
5,950 
<1 
1,620 
<1 
<1 
Assays were performed with twice frozen and thawed 20% cell extracts of antigen (vol/vol) 
as described (5, 6).  Concentrations  were determined  by extrapolation  to standard dose-re- 
sponse curves at the 10% intercept on a linearized scale normalized to 100% in the absence 
of added antigen. 
* Based on at least two separate preparations. 
the 30,000 dalton "gs" proteins of feline, woolly monkey (27), and RDll4  (28, 
29) type C  viruses. The sensitivity  of each of these assays in  their  particular 
homologous systems is  comparable  to or exceeds  that of the mouse  radioim- 
munoassay where 1-3 ng can be detected. 
Detection of Antigen  in Natural  Tissues.--Studies  of murine  gs antigens  in 
tissues  that  are free of demonstrable  infectious virus by complement fixation 
and  gel  diffusion  (30)  provide  another  means  of studying the  specificity and 
distribution of the reactivity measured by radioimlnunoassay in normal mouse 
cells. The C57 Leaden/Jax (L/J) strain has a very low incidence of tumors and 
rarely expresses  antigen  detectable  by complement fixation  until  very late  in 
life (H. Meier and R. J. Huebner, personal communication). Similarly, studies 
of BALB/c mice show an intermediate level of leukemias and lymphomas and 
infectious  virus  although  antigen  is  usually  not  detectable  by  complement 
fixation  before 6  mo of age  (31).  We  examined  different  groups of male  and 
female  C57L/J  at  weaning  (3  wk)  and,  as  shown  in  Table  II,  readily found 
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TABLE II 
Detection of Cross-Reactlng Murine gs Antigen in Tissue Preparations 
Species or strain  Organ  Concentration range* 
C57L/J 
BALB/c 
ng/mg protein 
Spleen  20-50 
Thymus  4-15 
Kidney  < 1-24 
Liver  22-36 
Muscle (cardiac)  < 1 
Spleen  12-330 
Kidney  5-52 
Muscle  < 1-12 
Feline  Spleen  < 1 
Human  Spleen  < 1 
Weanling C57L/J mice kindly supplied by Dr. Hans Meier, Jackson Laboratory, Bar Har- 
bor, Maine, were sacrificed by cervical dislocation, tissues were harvested,  and  20% extracts 
(vol/vol) were prepared as described (36). Weanling and young adult (<6 mo) BALB/c mice 
were supplied by Mr. Sam Poiley, NCI, NIH; extracts from five tumored cats and from three 
human lymphoma patients were kindly provided through Doctors Murray Gardner and Brian 
Henderson, USC, Los Angeles, Calif. 
* Based on at least three separate organs in each case. 
in a  given tissue were variable from mouse to mouse, but the lymphoid tissues 
(spleen  and thymus) were consistently positive. 
As in the tissue culture systems, BALB/c tissues were positive. The positives 
varied over a wider range than C57L/J tissues and were often higher; neverthe- 
less, the patterns of tissue reactivity were comparable with the C57L/J in that 
the  spleen  was  consistently  positive  and  muscle  tissue  low  or  negative.  Cat 
spleens  [positive for feline VP3(gs)]  and human  spleens  were negative  in the 
mouse  assay for the  mouse VP3(gs).  Positive  murine  tissues  did  not react in 
the feline,  woolly, or RDII4 gs protein  assays but were positive for the inter- 
species (gs-3) antigenic reactivity (32) by radioimmunoassay (7,  8). This organ 
distribution  of  viral  antigen  coincides  with  the  distribution  of  murine  gs 
antigens detected by complement fixation (30). Thus it appears that the murine 
radioimmunoassay can specifically measure an antigenic reaction in tissues,  as 
well  as in cell culture  systems, that is specific for murine tissues  and  shows a 
similar organ distribution to that noted later in life when the tissues have levels 
of antigen that can be detected with less sensitive methods. 
Dose-Response Curve of Murine  Cellular Reactivity.---As  shown in Fig.  1,  the 
addition of increasing amounts of NIH 3T3 or BALB/c 3T3 cells to the radio- 
immunoprecipitation  competition  assay  resulted  in  a  decreased  number  of 
[12~I[MVP3(gs)  counts being precipitated  by specific  antibody,  indicating  the PARKS,  LIVINGSTON, TODARO, BENVENISTE,  SCOLNICK  627 
presence of an unlabeled antigen. The displacement is only partial with uncon- 
centrated cell extracts since the levels of antigen in uninfected cell extracts are 
relatively low. Fig. 1 demonstrates that the degree of displacement of labeled 
antigen is complete using disrupted MuLV. 
The BALB/c 3T3 and NIH 3T3 mouse cell preparations, although differing 
slightly in their relative amounts of antigen, show a similar partial displacement 
with increasing concentrations. NRK does not displace labeled antigen at up to 
eight times greater concentrations of total cellular protein. Mixing experiments 
indicated that the NRK extracts do not contain an inhibitor that would inter- 
fere with detection of limiting amounts of MuLV gs antigen. 
Antibody Consumption by Extracts oJ Normal Mouse Cells.--The  radioim- 
munoprecipitation inhibition assay is  a  competition  assay between  the  test 
material and the highly purified [t25I]MVP3(gs) protein with limiting amounts 
of antibody. If the reaction noted with uninfected mouse cells in the mouse 
competition assay is  specific  for the MuLV virion protein,  MVP3(gs),  then 
tissue  extracts  should  adsorb  antibody prepared  against purified MVP3(gs) 
protein.  A  representative  antibody consumption  assay  with  NIH  3T3  cell 
extracts  and  monospecific  rabbit  anti-MVP3(gs)  sera  is  shown  in  Fig.  2. 
NIH 3T3  extracts specifically remove limiting concentrations of rabbit  anti- 
body against MVP3(gs) antigen. In the same experiment, quantitative studies 
with  purified  MVP3(gs)  protein  showed  the  antibody  consumption  assay 
easily detected 0.5-1.0 ng of antigen and was comparable to the sensitivity of 
the radioimmunoprecipitation inhibition assay (1-3 ng). Several of the murine 
cell lines described in Table I were tested in the antibody consumption test with 
results that were similar to those noted in  the standard competition assays. 
NRK cells  and  woolly monkey type  C  virus-infected cells  did  not  remove 
detectable antibody, and in parallel studies woolly type C virus antibody was 
not adsorbed  by the murine cell  extracts  (NIH 3T3)  or purified MVP3(gs) 
(data not shown). As a  control for that system, woolly type C virus-infected 
cells removed antibody to the woolly gs protein with an efficiency comparable 
to that noted in the homologous system. 
These results indicate that "normal" mouse cells specifically adsorb antibody 
to the MuLV group-specific protein and suggest that these cells, though con- 
taining  no  demonstrable  infectious  virus,  are  producing  a  cross-reacting 
antigen. 
Immunoajfinity Chromatography of M VP3(gs) and Cross-Reacting Antigen.- 
To partially purify the  cross-reacting  antigen  in  NIH  3T3  mouse  cells,  an 
affinity chromatographic  procedure  similar  to  that  described  for  the  viral 
reverse  transcriptase  was  employed  (22).  The  antibody  (IgG)  coupled  to 
Sepharose in this case was from a goat serum (IS-8) prepared against disrupted 
feline leukemia virus; by radioimmunoassay the serum contained a high anti- 
body  titer  (1:32,000)  to  the  interspecies  reactivity  of  mammalian  type  C 
viruses  (gs-3)  (32).  Since  species-specific  reactivity  (gs-1)  and  mammalian 
interspecies reactivity (gs-1) are contained on the same polypeptide (33), such 628  DETECTION  O~'  VIRAL  ANTIGEN  BY  RADIOIMMUNOASSAY 
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FIG. 2.  Antibody consumption. A 1:5000 dilution of rabbit anti-MVP3(gs)  (124 #g/ml) 
was mixed with equal volumes of extracts of NRK cells (O .... ©)  (21.5 mg/ml), NIH 3T3 
(O--O) (9.0 mg/ml), disrupted MuLV (Rauscher) ([~--[3) (0.00052 mg/ml), and NRK pro- 
ductively infected with  KiMuLV(MSV)  (B--I)  (8.6 mg/ml).  After 3 h  of incubation at 
37°C the mixtures were centrifuged at 100 g in an International  PR-6 centrifuge (International 
Equipment Co., Needham Heights, Mass.) at 4°C. The supernatant fluid was removed and 
titered for its ability to precipitate [125I]MVP3(gs) in a double antibody assay  method (6) 
compared with untreated antibody  (ZX--A). 
a  column was useful in purifying the reactivity [presumably mouse VP3(gs), 
i.e. gs-3] from the NIH 3T3 cells. To test the specificity of the imnmnoadsorbent 
for the mouse gs-1 protein, 125I-labeled  nmrine VP3(gs)  was applied either to 
the antibody column or to a  column coupled to nonimmune IgG. The results 
are shown in Fig. 3. The labeled antigen binds to and can be eluted with 1 M 
NH4OH  from  the IS  8-containing column but not  to  the  column containing 
control IgG. Thus the immunoadsorbent can be used to bind gs antigen. 
Immunological  Comparison  of Antigenic Reactivity  in  NIH  3T3  Cells with PARKS, LIVINGSTON, TODARO, BENVENISTE, SCOLNICK  629 
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FIG. 3.  Immunoaffinity chromatography  of [I1251MVP3(gs). 0.13 ml of [I125]MVP3(gs) 
(5,900 cpm) was applied to a 1 ml anti-gs-3 IgG-Sepharose  and a 1 ml nonimmune IgG-Sepha- 
rose column after having been equilibrated with buffer A. Column operations are as described 
in Materials and Methods. The first 5 fractions represent the buffer A wash, the next 3 the 
buffer B wash, and the last 10, the solution C eluate. Each fraction's volume was 1 ml. 1 ml of 
each fraction was counted in  10 ml Redi-Solv VI (Beckman Instruments, Inc., Fullerton, 
Calif.). 
Known MuLV  VP3(gs).--By employing concentrated material partially puri- 
fied by adsorption to and elution from the anti-gs-3 column, it was possible to 
obtain a complete dose response curve of the NIH cellular antigen and purified 
MuLV VP3(gs)  that  subsequently had been  similarly treated  by adsorption 
to and elution from the same column. As shown by the linearized plots in Fig. 4, 
the slopes of the dose-response curves are parallel, indicating that the antigens 
are highly related immunologically. Without a precise estimate of the amount 
of NIH antigen, it however cannot be concluded the antigens are identical. 
The slope of known MVP3(gs) was not affected by the treatments employed 
to prepare  the  NIH 3T3  cellular  reactivity since  the  treated  and  untreated 
materials  had  the  same  slope and  intercept.  These  data,  combined with  the 
antibody consumption data,  support  the  conclusion that  the  murine  cellular 
antigen is highly related to the virion VP3(gs) antigen. In preliminary studies 
using  guanidine-HC1  chromatography, the  major cross-reactivity of reactive 
NIH  antigen  has  approximately  the  same  molecular  weight  as  the  virion 
antigen (30,000 daltons). 
Detection  of  Viral-Specific  RNA  in  Normal  Mouse Cells.--An  independent 630  DETECTION  OF  VIRAL  ANTIGEN  BY  RADIOIMMUNOASSAY 
approach  to  demonstrate  the  expression  of  subinfectious  viral  information  in 
routine  cells  is  molecular  hybridization  (34).  By  employing  [3H]DNA  syn- 
thesized  from  the  viral  RNA  with  endogenous  viral  RNA-instructed  DNA 
polymerase, it is possible to detect significant amounts of virus-specific RNA by 
hybridization  (Table III). Increasing concentrations of NIH  3T3 cellular RNA 
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Fro. 4.  Dose-response curves of NIH 3T3 antigen and  MVP3(gs).  NIH 3T3 clone A anti- 
genic reactivity from approx. 2 X  109 cells was purified by adsorption to and elution from an 
anti-gs-3 immunoadsorbent.  Assays  were performed as described  (6, 7)  and in the legend to 
Fig.  1. Maximum cpm were 4,150  and in the presence of antibody without added unlabeled 
antigen, 1,810. The percentage precipitation at each antigen concentration was determined in 
duplicate and assayed at the same time as  purified  MVP3(gs). Linearization and linear  re- 
gression  analyses  were  as  described  in  Materials  and  Methods.  The  slope  of  the  purified 
MVP3(gs)  dose-response  curve (not graphed) was 1.475 with a variance of 0.0001. The slope of 
the MVP3(gs)  eluted from the immunoadsorbent  (A--A) was 1.494 with a variance of 0.005. 
The slope of the NIH 3T3 cell antigen (e--O)  was 1.456 with a variance of 0.006, The slope 
of the  MVP3(gs)  and  the NIH 3T3 cell antigen appeared  to be identical to  the standard, 
T[10]  =  0.258 and T[10] =  0.426, respectively. 
TABLE  III 
Hybridization of MuLV DNA  Product with RNA from NII1 Swiss 3T3 Cells 
Total cellular  RNA added 
S-1 nuclease-resistant counts 
Zero time  Hybridized  Difference 
Percent hybridized 
re  % 
I00  134  167  33  3 
310  172  248  76  6 
530  184  410  226  19 
Total cell RNA was extracted using sodium dodecyl sulfate and phenol. Reaction mixtures 
contained 1,204 [3H]DNA TCA-precipitable cpm. The details of the RNA  preparation,  the 
[3H]DNA product, and the analysis of hybridization by S-1 nuclease are  described  elsewhere 
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resulted in larger amounts (up to 19 %) of labeled DNA being resistant to an 
enzyme (S-1  nuclease)  that is specific for sin#e-stranded nucleic acids. NRK 
cell RNA that were employed for growing the virus bound less than 2 % of the 
labeled DNA at comparable levels of RNA. Other specificity tests and results 
in other cells are described in greater detail elsewhere (26). 
Tsuchida et al.  (34)  have reported the presence of viral-specific RNA in an 
unusual  virus-negative line of NIH  Swiss  murine  cells  (NIH-X),  which  has 
levels of MuLV gs antigen that are high enough to be detected by complement- 
fixation (CF) assay. Since the NIH 3T3 cell line we are studying has 10-50-fold 
less gs antigen than would be required for detection by CF,  the detection of 
viral-specific RNA  by  hybridization  strongly  supports  the  view  that  viral 
genes are being expressed at very low levels in  a  subinfectious form in  these 
cells. 
DISCUSSION 
The observation of an antigen in murine cells  that is structurally and im- 
munologically related to the type C viral group-specific (gs)  antigen strongly 
suggests some degree of expression of at least one type C viral gene in normal 
routine cells. Various lines of evidence have already led to the conclusion that 
there is  a  latent  type  C  viral  genome in  all  rodent  cells  (5,  35).  However, 
previous studies have generally implied that the genome in postembryonic cells 
is dormant until activated by age,  chemicals, radiation, or other factors. The 
present findings in virus-negative strains of mice indicate at least a portion of 
the viral genome is expressed widely, suggesting that host cell repression of the 
viral genome is not complete. Whether the expression is somehow linked to the 
cell growth cycle is not known. Further, present data do not allow one to dis- 
tinguish clearly between the possibility that the antigen being measured repre- 
sents a  low level of virus release or a  selective expression of a particular viral 
gene product in  the absence of virus production. The failure to isolate virus 
from the cells studied by the most sensitive biological assays  (focus-forming 
assays  from  nonproducers,  XC  test,  or  viral  polymerase-inducing  ability) 
support the latter view. 
Huebner et al. (36)  have reported the presence of murine gs antigen in NIH 
Swiss mouse embryos by CF tests and demonstrated by gel diffusion its identity 
to virion gs protein. Since there is an apparent absence of either morphologi- 
cally mature or infectious virus in these embryos, they postulated an association 
between  factors  controlling  gs  antigen  expression  and  growth.  Abelev  and 
Elgort (37)  have independently reported the presence of MuLV gs antigen in 
both embryonic and adult tissues from low leukemic incidence strains of mice 
such as C57BL/6 and BALB/c using indirect immunoautoradiography. 
Unless some threshold phenomena exists, it seems likely that the presence of 
this particular viral  structural  gs protein is  not in  itself a  "determinant" of 
cellular  transformation  since  morphologically normal  cells  contain  levels  of 632  DETECTION  OF  VIRAL  ANTIGEN  BY  RADIOIMMUNOASSAY 
antigen comparable to those found in transformed tumorigenic cells in culture. 
Neither spontaneous  transformation,  transformation by DNA  tumor viruses, 
nor  radiation-induced  transformation  significantly  increase  the  levels  of  ex- 
pression of this viral gene product (Table I). Therefore, transformation per se 
does not necessarily increase the expression of all type C viral gene functions; 
however, the transforming functions may be coded for by other portions of the 
viral genome. 
Since the increased expression of the viral gs antigen during embryogenesis 
qualifies it as an "embryonic" antigen, the existence of low levels of this antigen 
in  adult  mouse  tissues  has  parallelisms  with  certain  tumor-associated  em- 
bryonic antigens (38-40). In mice, the loss of host cell repression of the synthe- 
sis of gs antigen has a strong correlation with an increased risk for the develop- 
ment of 1)anphoid tumors.  2 Similarly, the levels of certain embryonic antigens 
is increased in the serum of animals or patients with certain types of tumors. 
If common biological mechanisms are involved in the regulation of these pro- 
teins  and  of transformation,  questions  concerning  a  viral  etiology of  tumors 
would involve another dimension. The existence of vertically transmitted viral 
genes (36)  will require different approaches to establish cause and effect than 
those that have been previously applicable to epigenetic factors in disease. 
Finally, the finding that host cell RNA from normal murine cells specifically 
hybridizes with murine type C  viral DNA product provides an essential sup- 
port for the finding of a viral protein, and vice versa. It would appear that a 
combination  of  both  nucleic  acid  hybridization  for  the  detection  of  viral- 
specific RNA and sensitive immunological assays for viral proteins might pro- 
vide  a  stronger approach for detecting  low levels of viral expression in other 
species than does either alone. 
SUMMARY 
A radioimmunoassay specific for a murine leukemia virus structural protein, 
the gs antigen, detects an antigenic reactivity in normal murine cells in culture 
and natural tissues. The assay was shown to measure an antigen that is highly 
related to  the virion protein as shown by absorption tests,  immunoadsorbent 
chromatography,  and  by  analysis  of  linearized  dose-response  curves.  These 
findings combined with the finding of viral-specific RNA indicate that portions 
of the viral genome are being expressed with a  much greater frequency than 
previously appreciated. 
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